IMMX
Price
$3.50
Change
+$0.15 (+4.48%)
Updated
Mar 1, 6:59 PM EST
REVB
Price
$3.64
Change
-$0.01 (-0.27%)
Updated
Mar 1, 6:59 PM EST
Ad is loading...

Compare trend and price IMMX vs REVB

Header iconIMMX vs REVB Comparison
Open Charts IMMX vs REVBBanner chart's image
Immix Biopharma
Price$3.50
Change+$0.15 (+4.48%)
Volume$142.81K
CapitalizationN/A
Revelation Biosciences
Price$3.64
Change-$0.01 (-0.27%)
Volume$178.69K
CapitalizationN/A
View a ticker or compare two or three
IMMX vs REVB Comparison Chart

Loading...

IMMXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
REVBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
IMMX vs. REVB commentary
Mar 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a StrongSell and REVB is a StrongSell.

COMPARISON
Comparison
Mar 02, 2024
Stock price -- (IMMX: $3.50 vs. REVB: $3.64)
Brand notoriety: IMMX and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 44% vs. REVB: 39%
Market capitalization -- IMMX: $89.12M vs. REVB: $1.44M
IMMX [@Biotechnology] is valued at $89.12M. REVB’s [@Biotechnology] market capitalization is $1.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $530.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whileREVB’s FA Score has 3 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • REVB’s FA Score: 3 green, 2 red.
According to our system of comparison, REVB is a better buy in the long-term than IMMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 4 TA indicator(s) are bullish while REVB’s TA Score has 4 bullish TA indicator(s).

  • IMMX’s TA Score: 4 bullish, 5 bearish.
  • REVB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, REVB is a better buy in the short-term than IMMX.

Price Growth

IMMX (@Biotechnology) experienced а +15.13% price change this week, while REVB (@Biotechnology) price change was +30.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was +20.20%, and the average quarterly price growth was +48.09%.

Reported Earning Dates

IMMX is expected to report earnings on Feb 28, 2024.

REVB is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for IMMX with price predictions.
OPEN
A.I.dvisor published
a Summary for REVB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IMMX($85.8M) has a higher market cap than REVB($1.45M). IMMX YTD gains are higher at: -49.422 vs. REVB (-75.767). REVB has higher annual earnings (EBITDA): -7.52M vs. IMMX (-14.21M). IMMX has more cash in the bank: 19.6M vs. REVB (14M). REVB has less debt than IMMX: REVB (0) vs IMMX (50K). IMMX (0) and REVB (0) have equivalent revenues.
IMMXREVBIMMX / REVB
Capitalization85.8M1.45M5,930%
EBITDA-14.21M-7.52M189%
Gain YTD-49.422-75.76765%
P/E RatioN/A0.52-
Revenue00-
Total Cash19.6M14M140%
Total Debt50K0-
TECHNICAL ANALYSIS
Technical Analysis
IMMXREVB
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
41%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
50%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
45%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
50%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
64%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMMXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
REVBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENLAY6.31N/A
N/A
ENEL Societa per Azioni
LKNCY22.03N/A
N/A
Luckin Coffee Inc.
TTNDY53.85N/A
N/A
Techtronic Industries Ltd.
GLASF6.95N/A
N/A
Glass House Brands
PEXZF0.07N/A
N/A
Pacific Ridge Exploration Ltd.

IMMX and

Correlation & Price change

A.I.dvisor tells us that IMMX and AVRO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMX and AVRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
+4.17%
AVRO - IMMX
30%
Poorly correlated
N/A
ORMP - IMMX
27%
Poorly correlated
+4.27%
PDSB - IMMX
25%
Poorly correlated
+0.08%
PRTC - IMMX
24%
Poorly correlated
+2.10%
UBX - IMMX
23%
Poorly correlated
-1.64%
More

REVB and

Correlation & Price change

A.I.dvisor tells us that REVB and TOVX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that REVB and TOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-0.27%
TOVX - REVB
31%
Poorly correlated
+4.13%
TSHA - REVB
31%
Poorly correlated
+2.05%
LEGN - REVB
27%
Poorly correlated
+0.58%
CNSP - REVB
26%
Poorly correlated
+12.28%
NVIVQ - REVB
26%
Poorly correlated
N/A
More